246
effective, saving thousands of lives. However, works on prevention of KS is still
slow. No vaccines or other drugs have been found or developed in preventing KSHV
infection or KS development. And works on non-AIDS-related KS still need more
attention.
References
- Martin JN et al (1998) Sexual transmission and the natural history of human herpesvirus 8
infection. N Engl J Med 338(14):948–954 - Mendez JC et al (1999) Relationship of HHV8 replication and Kaposi’s sarcoma after solid
organ transplantation. Transplantation 67(8):1200–1201 - Martin RR, Hood AF, Farmer ER (1993) Kaposi sarcoma. Medicine (Baltimore)
72(4):245–261 - Sternbach G, Varon J (1995) Moritz Kaposi: idiopathic pigmented sarcoma of the skin.
J Emerg Med 13(5):671–674 - Begré L et al (2016) Is human herpesvirus 8 infection more common in men than in women?
Systematic review and meta-analysis. Int J Cancer 139(4):776–783 - Wu XJ et al (2014) One hundred and five Kaposi sarcoma patients: a clinical study in
Xinjiang, Northwest of China. J Eur Acad Dermatol Venereol 28(11):1545–1552 - Biryahwaho B et al (2010) Sex and geographic patterns of human herpesvirus 8 infection in a
nationally representative population-based sample in Uganda. J Infect Dis 202(9):1347–1353 - Butler LM et al (2011) Human herpesvirus 8 infection in children and adults in a population-
based study in rural Uganda. J Infect Dis 203(5):625–634 - Engels EA et al (2007) Risk factors for human herpesvirus 8 infection among adults in the
United States and evidence for sexual transmission. J Infect Dis 196(2):199–207 - Zhang T et al (2012) Human herpesvirus 8 seroprevalence. China Emerg Infect Dis
18(1):150–152 - Bhutani M et al (2015) Kaposi sarcoma-associated herpesvirus-associated malignancies: epi-
demiology, pathogenesis, and advances in treatment. Semin Oncol 42(2):223–246 - O’Brien TR et al (1999) Evidence for concurrent epidemics of human herpesvirus 8 and
human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and rela-
tionship to Kaposi’s sarcoma. J Infect Dis 180(4):1010–1017 - Regamey, N., et al., (1998) High human herpesvirus 8 seroprevalence in the homosexual
population in Switzerland. J Clin Microbiol 36(6):1784–1786 - Zhang T et al (2013) Prevalence and correlates of Kaposi’s sarcoma-associated herpesvirus
infection in a sample of men who have sex with men in Eastern China. Epidemiol Infect
141(9):1823–1830 - Casper C et al (2004) HIV infection and human herpesvirus-8 oral shedding among men who
have sex with men. J Acquir Immune Defic Syndr 35(3):233–238 - Pauk J et al (2000) Mucosal shedding of human herpesvirus 8 in men. N Engl J Med
343(19):1369–1377 - Rohner E et al (2014) HHV-8 seroprevalence: a global view. Syst Rev 3:11
- Rohner E et al (2016) HIV and human herpesvirus 8 co-infection across the globe: systematic
review and meta-analysis. Int J Cancer 138(1):45–54 - Feiterna-Sperling C et al (2016) High seroprevalence of antibodies against Kaposi’s sarcoma-
associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-
endemic population. Med Microbiol Immunol 205:425–434 - Uldrick TS, Whitby D (2011) Update on KSHV epidemiology, Kaposi sarcoma pathogenesis,
and treatment of Kaposi sarcoma. Cancer Lett 305(2):150–162
J. Qin and C. Lu